This year’s flagship event will gather top EU, US, Asia and global regulators, officials, healthcare actors as well as industry leaders, to foster open exchange and debate on the role of the biosimilar & biologics medicines sector.
Biobanking 2019 is the leading event to get through the biobanking’s ever-thriving market and convenes key stakeholders from the field, and innovator pharmaceutical manufacturers, payers, providers and patient advocates addressing timely challenges and best practices for biobanking product success.
Biosimilars & Biologics 2019 is the leading event to continually stay on the pulse of the biosimilars’ ever-changing market and convenes key stakeholders including biosimilar and innovator pharmaceutical manufacturers, payers, providers and patient advocates addressing timely challenges and best practices for biosimilar product success
Orphan Drugs for Rare Diseases 2019 will help connect industry professionals internationally, ensuring there is a great networking and learning opportunity to share knowledge of research, developments and issues.
The Gut-Axis Summit 2019 will be dedicated to help large pharma, biotech, academics and clinicians exploring and understand the Human Microbiome Market, GBA in demonstrating disease causation and changing perceptions of bacteria in the Skin Microbiome. Over the last decade, the microbiome has become one of the trendiest areas of biology, and the research has made clear that the microbiome is fundamental to overall health.